Sunshine Biopharma (SBFM) Return on Sales Growth (1y) (2019 - 2026)

Sunshine Biopharma (SBFM) Return on Sales Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 0.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 0.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 0.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.00
10 Sunshine Biopharma 10.94 Mn 4.03 Mn 2.18 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 -1.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 1.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 6.00
Sep 30, 2023 11.00
Jun 30, 2023 3.00
Mar 31, 2023 10.00
Dec 31, 2022 -14.00
Sep 30, 2022 69.00
Jun 30, 2022 51.00
Mar 31, 2022 144.00
Jun 30, 2021 -54.00
Mar 31, 2021 -154.00
Jun 30, 2020 1.00